Latest Breaking News On - Reuters south africa - Page 4 : comparemela.com

3 Min Read CAPE TOWN (Reuters) - South Africa aims to immunise between 350,000 and 500,000 health workers with Johnson & Johnson’s COVID-19 vaccine in an “implementation study” to further evaluate the shot, the president of the country’s Medical Research Council said. Glenda Gray, co-lead investigator on the local leg of a J&J global trial, told Reuters South Africa expected to get batches of around 80,000 doses every seven to 14 days for the study, once it is approved. The implementation study would be aimed at further evaluating J&J’s vaccine in the field and would be akin to a phase IIIb study, Gray said. J&J’s vaccine has already been tested in the global phase III trial involving more than 40,000 participants including over 6,000 in South Africa.

South africaUnited statesZweli mkhizeWendell roelfGlenda grayAlison williamsThomson reuters trust principlesDrug administrationResearch councilMedical research councilReuters south africaMinister zweli mkhizeAlexander winningThomson reuters trustCorona virusCompany news